Iontophoresis: Applications in drug delivery and noninvasive monitoring

Transdermal Drug Delivery, Second Edition: Revised and Expanded

Volumn , Issue , 2002, Pages 199-225

  Delgado Charro, M Begoña ^a,b   Guy, Richard H ^a,b  

^a Centre Interuniversitaire de Recherche et d'Enseignement   (France)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056976245     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (95)

1. RR Burnette. Iontophoresis. In: J Hadgraft, RH Guy, eds. Transdermal drug delivery. Developmental issues and research initiatives. New York: Marcel Dekker, 1989, pp 247-291.
2. N Harper-Bellantone, S Rim, ML Francoeur, B Rasadi. Enhanced percutaneous absorption via iontophoresis I. Evaluation of an in vitro system and transport model compounds. Int J Pharm 30:63-72, 1986.
3. P Tyle. Iontophoretic devices for drug delivery. Pharm Res 3:318-326, 1986.
4. + is critical for inhibition of palmar sweating by iontophoresis in water. J Appl Physiol, 75:2258-2264, 1993.
5. RH Guy. Current status and future prospects of transdermal delivery. Pharm Res 13:1765-1769, 1996.
6. LP Gangarosa, N Park, CA Wiggins, JM Hill. Increased penetration of nonelectrolytes into mouse skin during iontophoretic water transport (iontohy-drokinesis). J Pharmacol Exp Ther 212:377-381, 1980.
7. MJ Pikal. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev 9:201-237, 1992.
8. P Glikfeld, RS Hinz, RH Guy. Noninvasive sampling of biological fluids by iontophoresis. Pharm Res 6:988-990, 1989.
9. BH Sage, JE Riviere. Model systems in iontophoresis transport efficacy. Adv Drug Deliv Rev, 9:265-287, 1992.
10. JB Phipps, JR Gyory. Transdermal ion migration. Adv Drug Deliv Rev 9: 137-176, 1992.
11. ER Scott, B Phipps, R Gyory, RV Padmanabhan. Electrotransport systems for transdermal delivery: a practical implementation of iontophoresis. In: DL Wise, ed. Handbook of Pharmaceutical Controlled Release Technology. New York: Marcel Dekker, 2000, pp 617-659.
12. JB Phipps, RV Padmanabhan, GA Lattin. Iontophoretic delivery of model inorganic and drug ions. J Pharm Sci 78:365-369, 1989.
13. C Cullander, G Rao, RH Guy. Why silver/silver chloride? Criteria for iontophoresis electrodes. In: KR Brain, VJ James, KA Walters, eds. Prediction of Percutaneous Penetration. Cardiff: STS, 1993, pp 381-390.
14. CL Gay, PG Green, RH Guy, ML Francoeur. Iontophoretic delivery of piroxicam across the skin. J Control Rel 22:57-68, 1992.
15. PG Green, RS Hinz, C Cullander, G Yamane, RH Guy. Iontophoretic delivery of a series of amino acids and amino acid derivatives across the skin “in vitro.” Pharm Res 8:1113-1120, 1991.
16. PG Green, RS Hinz, A Kim, FC Szoka, RH Guy. Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm Res 8:1121-1127, 1991.
17. RM Brand, PL Iversen. Iontophoretic delivery of a telomeric oligonucleotide. Pharm Res 13:851-854, 1996.
18. MB Delgado-Charro, RH Guy. Iontophoretic delivery of nafarelin across the skin. Int J Pharm 117:165-172, 1995.
19. LL Miller, CJ Kolaskie, GA Smith, J Riviere. Transdermal iontophoresis of gonadotropin releasing hormone (LHRH) and two analogues. J Pharm Sci 79:490-493, 1990.
20. R Van der Geest, F Hueber, FC Szoka Jr., RH Guy. Iontophoresis of bases, nucleosides and nucleotides. Pharm Res 13:553-558, 1996.
21. RM Brand, A Wahl, PI Iversen. Effects of size and sequence on the iontophoretic delivery of oligonucleotides. J Pharm Sci 87:49-52, 1998.
22. A Jadoul, J Mesens, W Caers, F de Beukelaar, R Crabbe, V Préat. Transdermal permeation of alnitidan by iontophoresis: in vitro optimization and human pharmacokinetic data. Pharm Res 13:1348-1353, 1996.
23. A Luzardo-Alvarez, MB Delgado-Charro, J Blanco-Méndez. Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation. Pharm Res 18:1714-1720, 2001.
24. D Marro, YN Kalia, MB Delgado-Charro, RH Guy. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res18:1701-1708, 2001.
25. GB Kasting, JC Keister. Application of electrodiffusion theory for an homogeneous membrane to iontophoretic transport through skin. J Control Rel8:195-210, 1989.
26. PW Ledger. Skin biological issues in electrically enhanced transdermal delivery. Adv Drug Deliv Rev 9:289-307, 1992.
27. RH Padmanabhan, JB Phipps, GA Lattin, RJ Sawchuk. In vitro and in vivo evaluation of transdermal iontophoretic delivery of hydromorphone. J Control Rel 11:123-135, 1990.
28. th International Symposium on Controlled Release of Bioactive Materials, San Diego, 2001, pp 184-185.
29. RM Brand, RH Guy. Iontophoresis of nicotine in vitro: pulsatile drug delivery across the skin? J Control Rel 33:285-292, 1995.
30. P Singh, MS Roberts, HI Maibach. Modelling of plasma levels of drugs following transdermal iontophoresis. J Control Rel 33:293-298, 1995.
31. SK Gupta, M Southam, G Sathyan, M Klausner. Effect of current density on pharmacokinetics following continuous or intermittent input from a fentanyl electrotransport system. J Pharm Sci 87:976-981, 1998.
32. K Sugibayashi, M Kagino, S Numajiri, N Inoue, D Kobayashi, M Kimura, M Yamaguchi, Y Morimoto. Synergistic effects of iontophoresis and jet injector pretreatment on the in vitro skin permeation of diclofenac and angiotensine II. J Pharm Pharmacol 52:1179-1186, 2000.
33. KR Oldenburg, KT Vo, GA Smith, HE Selick. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin. J Pharm Sci 84: 915-921, 1995.
34. RH Guy, MB Delgado-Charro, YK Kalia. Iontophoretic transport across the skin. Skin Pharmacol Appl Skin Physiol 14(suppl):35-40, 2001.
35. NH Yoshida, MS Roberts. Solute molecular size and transdermal iontophoresis across excised human skin. J Control Rel 25:177-195, 1993.
36. M Clemessy, G Couarraze, B Bevan, F Puisieux. Mechanisms involved in iontophoretic transport of angiotensine. Pharm Res 12:998-1002, 1995.
37. PP Sarpotdar, CR Daniels. Use of polymeric buffers to facilitate iontophoretic transport of drugs. Pharm Res 7:S185, 1990.
38. TS Sahota, RJ Latham, RG Lindford, PM Taylor. Polymer electrolyte materials for use in iontophoretic drug delivery. In: PI Harris, D Chapman, eds. New Biomedical Materials. Basic and Applied Studies. Amsterdam: IOS Press, 1998, pp 143-148.
39. NN Turner, C Cullander, RH Guy. Determination of the pH gradient across stratum corneum. J Invest Dermatol 3:110-113, 1998.
40. YW Chien, O Siddiqui, Y Sun, WV Shi, JC Liu. Transdermal iontophoretic delivery of therapeutic peptides/proteins I: Insulin. Annals New York Acad Sci 507:32-51, 1987.
41. J Hirvonen, F Hueber, RH Guy. Current profiles regulates iontophoretic delivery of aminoacids across the skin. J Control Rel 37:239-249, 1995.
42. RR Burnette, D Marrero. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J Pharm Sci 75:738-743, 1986.
43. F Helfferich. Ion Exchange. New York: Dover, 1995, pp 323-338.
44. MJ Pikal. Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis. Pharm Res 7:118-126, 1990.
45. RR Burnette, B Ongpipattanakul. Characterization of the permselective properties of excised human skin during iontophoresis. J Pharm Sci 76: 765-773, 1987.
46. PH Barry, AB Hope. Electroosmosis in membranes: effects of unstirred layers and transport numbers. II. Experimental. Biophysical Journal 9:729-757, 1969.
47. MJ Pikal, S Shah. Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurements for hairless mouse skin. Pharm Res 7:213-221, 1990.
48. MJ Pikal, S Shah. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm Res7:222-231, 1990.
49. GB Kasting, LA Bowman. DC electrical properties of frozen, excised human skin. Pharm Res 7:134-143, 1990.
50. JD DeNuzzio, B Berner. Electrochemical and iontophoretic studies of human skin. J Control Rel 11:105-112, 1990.
51. A Kim, PG Green, G Rao, RH Guy. Convective solvent flow across the skin during iontophoresis. Pharm Res 10:1315-1320, 1993.
52. D Marro, R Guy, MB Delgado-Charro. Characterization of the iontopho-retic permselectivity properties of human and pig skin. J Control Rel 70: 213-217, 2001.
53. A Luzardo-Alvarez, M Rodriguez-Fernandez, J Blanco-Mendez, R Guy, MB Delgado-Charro. Iontophoretic permselectivity of mammalian skin: characterization of hairless mouse and porcine membrane models. Pharm Res 15:984-987, 1998.
54. V Merino, A López, YN Kalia, RH Guy. Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5fluorouracil. Pharm Res 16:758-761, 1999.
55. BD Bath, HS White, ER Scott. Visualization and analysis of electroosmotic flow in hairless mouse skin. Pharm Res 17:471-475, 2000.
56. P Santi, RH Guy. Reverse iontophoresis. Parameters determining electroosmotic flow: I. pH and ionic strength. J Control Rel 38:159-165, 1996.
57. V Merino, A Lopez, D. Hochstrasser, RH Guy. Noninvasive sampling of phenylalanine by reverse iontophoresis. J Control Rel 61:65-69, 1999.
58. J Hirvonen, RH Guy. Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances. Pharm Res 14:1258-1263, 1997.
59. MB Delgado-Charro, RH Guy. Iontophoresis of peptides. In: B Berner, SM Dinh, eds. Electronically Controlled Drug Delivery. Boca Raton: CRC Press, 1989.
60. MB Delgado-Charro, R Guy. Characterization of convective solvent flow during iontophoresis. Pharm Res 11:929-935, 1994.
61. AJ Hoogstrate, V Srinivasan, SM Sims, WI Higuchi. Iontophoretic enhancement of peptides: behaviour of leuprolide versus model permeants. J Control Rel 31:41-47, 1994.
62. J Hirvonen, YN Kalia, RH Guy. Transdermal delivery of peptides by iontophoresis. Nature Biotech. 14:1710-1713, 1996.
63. P Santi, RH Guy. Reverse iontophoresis parameters determining electroosmotic flow: II. Electrode chamber formulation. J Control Rel 42:29-36, 1996.
64. P Singh, M Anliker, GA Smith, D Zavortink, HI Maibach. Transdermal iontophoresis and solute penetration across excised human skin. J Pharm Sci 84:1342-1346, 1995.
65. D Marro, YN Kalia, MB Delgado-Charro, RH Guy. Optimizing iontophoretic drug delivery: identification and distribution of the charge carrying species. Pharm Res, in press.
66. RH Guy, YN Kalia, MB Delgado Charro, V Merino, A Lopez, D Marro. Iontophoresis: electrorepulsion and electroosmosis. J Control Rel 64:129-132, 2000.
67. NM Volpato, P Santi, P Colombo. Iontophoresis enhances the transport of acyclovir through nude mouse skin by electrorepulsion and electroosmosis. Pharm Res 12:1623-1627, 1995.
68. G Rao, RH Guy, P Glikfeld, WR LaCourse, L Leung, J Tamada, R Potts, N Azimi. Reverse iontophoresis: noninvasive glucose monitoring in vivo in humans. Pharm Res 12:1869-1873, 1995.
69. C Cullander. What are the pathways of iontophoretic current flow through mammalian skin? Adv Drug Deliv Rev 9:119-135, 1992.
70. ER Scott, AI Laplaza, HS White, JB Phipps. Transport of ionic species in skin: contribution of pores to overall skin conductance. Pharm Res 10: 1699-1709, 1993.
71. ER Scott, JB Phipps, HS White. Direct imaging of molecular transport through skin. J Invest Dermatol 104:142-145, 1995.
72. BD Bath, ER Scott, JB Phipps, HS White. Scanning electrochemical microscopy of iontophoretic transport in hairless mouse skin. Analysis of the relative contributions of diffusion, migration, and electroosmosis to transport in hair follicles. J Pharm Sci 89:1537-1549, 2000.
73. NA Monteiro-Riviere, AO Inman, JE Riviere. Identification of the pathway of iontophoretic drug delivery: light and ultrastructural studies using mercuric chloride in pigs. Pharm Res 11:251-256, 1994.
74. NG Turner, RH Guy. Iontophoretic transport pathways: dependence on penetrant physicochemical properties. J Pharm Sci 86:1385-1389, 1997.
75. NG Turner, RH Guy. Visualization and quantitation of iontophoretic pathways using confocal microscopy. J Invest Dermatol Symp Proceed 3:136-142, 1998.
76. PG Green. Iontophoretic delivery of peptide drugs. J Control Rel 41:3348, 1996.
77. L Langkjaer, J Brange, GM Grodsky, RH Guy. Iontophoresis of monomeric insulin analogues in vitro: effects of insuline charge and skin pretreatment. J Control Rel 51:47-56, 1998.
78. M Cormier, ST Chao, SK Gupta, R Haak. Effect of transdermal iontophoresis codelivery of hydrocortisone on metoclopramide pharmacokinetics and skin induced reactions on human subjects. J Pharm Sci 88:1030-1035, 1999.
79. R Van der Geest, M Danhof, HE Bodde. Iontophoretic delivery of apomor-phine I: in vitro optimization and validation. Pharm Res 14:1798-1803, 1997.
80. R Van der Geest, T van Laar, JM GubbensStibbe, HE Bodde, M Danhof. Iontophoretic delivery of apomorphine II: an in vivo study in patients with Parkinson’s disease. Pharm Res 14:1804-1810, 1997.
81. S Thysman, V Préat. In vivo iontophoresis of fentanyl and sufentanil in rats: pharmacokinetics and acute antinoceptive effects. Anesth Analg 77: 61-66, 1993.
82. LP Gangarosa, JM Hill. Modern iontophoresis for local delivery. Int J Pharm 123:159-171, 1995.
83. JM Hill, LP Gangarosa, NH Park. Iontophoretic application of antiviral chemotherapeutic agents. Ann NY Acad Sci, 284:604-612, 1977.
84. NM Volpato, S Nicoli, C Laureri, P Colombo, P Santi. In vitro acyclovir distribution in human skin layers after transdermal iontophoresis. J Control Rel 50:291-296, 1998.
85. B Marconi, F Mancini, P Colombo, F Allegra, F Giordano, A Gazzaniga, G Orecchia, P Santi. Distribution of khellin in excised human skin following iontophoresis and passive dermal transport. J Control Rel 60:261-268, 1999.
86. MJ Alvarez-Figueroa, MB Delgado-Charro, J Blanco-Mendez. Passive and iontophoretic transdermal penetration of methotrexate. Int J Pharm 212: 101-107, 2001.
87. JE Riviere, NA Monteiro-Riviere, AO Inman. Determination of lidocaine concentrations in skin after transdermal iontophoresis: effects of vasoactive drugs. Pharm Res 9:211-214, 1992.
88. RFV Lopez, MVLB Bentley, MB Delgado-Charro, R Guy. Iontophoretic delivery of 5aminolevulinic acid (ALA): effect of pH. Pharm Res 18:311-315, 2001.
89. S Gerscher, JP Connelly, J Griffiths, SB Brown, AJ MacRobert, G Wong, LE Rhodes. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. Photochemistry and Photobiology 72:569-574, 2000.
90. RM Brand, PL Iversen. Transdermal delivery of antisense compounds. Adv Drug Del Rev 44:51-57, 2000.
91. RM Brand, K Haase, TL Hannah, PL Iversen. An experimental model for interpreting percutaneous penetration of oligonucleotides that incorporates the role of keratinocytes. J Invest Dermatol, 111:1166-1171, 1998.
92. RM Brand, TL Hannah, J Norris, PL Iversen. Transdermal delivery of antisense oligonucleotides can induce changes in gene expression in vivo. Antisense and Nucleic Acid Drug Dev 11:1-6, 2001.
93. JA Tamada, S Garg, L Jovanovic, KR Pitzer, RO Potts. Noninvasive glucose monitoring. Comprehensive clinical results. JAMA, 282:1839-1844, 1999.
94. th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit 23:477, 2001.
95. th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit 23:476, 2001.